Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review

Adverse drug events (ADEs) represent one of the most prevalent types of health-care-related harm, and there is substantial room for improvement in the way that they are currently predicted and detected. We conducted a scoping review to identify key use cases in which artificial intelligence (AI) cou...

Full description

Bibliographic Details
Main Authors: Amato, M.G (Author), Bain, P.A (Author), Bates, D.W (Author), Co, Z. (Author), Dulgarian, S. (Author), Edrees, H. (Author), Foer, D. (Author), Kuznetsova, M. (Author), Purcell Jackson, G. (Author), Rhee, K. (Author), Seger, D.L (Author), Simona, A. (Author), Song, W. (Author), Syrowatka, A. (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2022
Subjects:
Online Access:View Fulltext in Publisher